SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures
16 references·0 citing·32 second hop
A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures (2013)A systematic review of models used in cos…Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic …Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic …Which patients do I treat? An experimental study with economists and physicians (2012)Which patients do I treat? An…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Preferred reporting items for…Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred Reporting Items for…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for…Decision Modelling For Health Economic Evaluation (2006)Decision Modelling For Health…Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Principles of Good Practice f…Modeling for Health Care and Other Policy Decisions: Uses, Roles, and Validity (2001)Modeling for Health Care and …Impact of Hip and Vertebral Fractures on Quality-Adjusted Life Years (2001)Impact of Hip and Vertebral F…Assessing Quality in Decision Analytic Cost-Effectiveness Models (2000)Assessing Quality in Decision…An Introduction to Markov Modelling for Economic Evaluation (1998)An Introduction to Markov Mod…Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life (1997)Modelling in Ecomomic Evaluat…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Guidelines for authors and pe…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Markov Models in Medical Decision Making (1993)Markov Models in Medical Deci…Methods for the economic evaluation of health care programmes (1987)Quality of life and pharmacoeconomics in clinical trials (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Inductive Teaching and Learning Methods: Definitions, Comparisons, and Research Bases (2006)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &c (1825)Handling Uncertainty in Cost-Effectiveness Models (2000)A rational framework for decision making by the National Institute For Clinical Excellence (NICE) (2002)A taxonomy of model structures for economic evaluation of health technologies (2006)Deciphering death: a commentary on Gompertz (1825) ‘On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies’ (2015)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Model Transparency and Validation (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)Model Parameter Estimation and Uncertainty Analysis (2012)Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 (2012)
this work references cited by second hop

References

  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement83,813 cited
  • 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement63,979 cited
  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.44,857 cited
  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2006Decision Modelling For Health Economic Evaluation3,144 cited
  • 1993Markov Models in Medical Decision Making2,411 cited
  • 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ1,821 cited
  • 2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement1,776 cited
  • 2003Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies1,170 cited
  • 1998An Introduction to Markov Modelling for Economic Evaluation960 cited
  • 1997Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life595 cited
  • 2001Impact of Hip and Vertebral Fractures on Quality-Adjusted Life Years240 cited
  • 2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement231 cited
  • 2000Assessing Quality in Decision Analytic Cost-Effectiveness Models212 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2001Modeling for Health Care and Other Policy Decisions: Uses, Roles, and Validity190 cited
  • 2012Which patients do I treat? An experimental study with economists and physicians117 cited
  • Cited by

    No citing works inside the corpus for this window.